Addison Advisors’s Bio-Techne TECH Stock Holding History

Addison Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19K	Hold	363	–	–	﹤0.01%	563
2025 Q4	$21.3K	Hold	363	–	–	﹤0.01%	538
2025 Q3	$20.2K	Sell	363 -44	-11%	-$2.36K	﹤0.01%	552
2025 Q2	$20.9K	Buy	407 +247	+154%	+$12.4K	0.01%	538
2025 Q1	$9.38K	Hold	160	–	–	﹤0.01%	590
2024 Q4	$11.5K	Buy	+160	New	+$11.7K	﹤0.01%	570

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Addison Advisors's TECH Position: Q1 2026 in Review

Addison Advisors held its Bio-Techne (TECH) position steady in Q1 2026 at 363 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

Addison Advisors first reported a position in TECH in Q4 2024 and has held it in 6 quarters since. The position peaked at $21.3K in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Addison Advisors held 363 shares of Bio-Techne worth $19K as of Q1 2026.
Addison Advisors left its Bio-Techne share count unchanged in Q1 2026.
Bio-Techne made up ﹤0.01% of Addison Advisors's portfolio in Q1 2026, its #563 holding.
Addison Advisors first reported a position in Bio-Techne in Q4 2024 and has held it in 6 quarters since.
Addison Advisors's Bio-Techne position peaked at $21.3K in Q4 2025.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.